The influence of poor vaccination uptake among African, Caribbean, and Black (ACB) communities.
FDA delays PDUFA date for Rocket’s rare white blood cell disorder gene therapy
The FDA’s decision on Rocket Pharmaceuticals’ autologous gene therapy for a rare white blood cell disorder has been pushed back by three months to June